NextCure Inc (NAS:NXTC)
$ 1.38 -0.05 (-3.5%) Market Cap: 38.60 Mil Enterprise Value: -40.84 Mil PE Ratio: 0 PB Ratio: 0.45 GF Score: 39/100

NextCure Inc at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 06:00PM GMT
Release Date Price: $52.9 (-0.71%)
Unidentified Analyst

Good morning, everyone. My name is Ray Wang, and I am a member of the JPMorgan Health Care Investment Banking team. Thank you all for coming here this morning. And just wanted to let you know the breakout room will be in the Olympic room outside to the left. And now it is my pleasure to introduce Michael Richman, President and CEO of NextCure.

Michael S. Richman
NextCure, Inc. - Co-Founder, CEO, President & Director

Thank you very much, Raymond. And I'd like to thank the JPMorgan staff for giving us the opportunity to present today. This is our first time at JPMorgan, and it's a pleasure to be here to introduce NextCure to all of you.

We started NextCure 4 years ago with the mission to develop these next-generation immuno medicines, and that's what we'll be walking through today. I'd just like to introduce our forward-looking statement slide.

But let me tell you about NextCure and some of the highlights that we've been focused on and that we've achieved over the last 4 years. We call these our 3 Ps: Our pipeline; our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot